MetLife Investment Management’s Enliven Therapeutics ELVN Stock Holding History

MetLife Investment Management’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$425K	Sell
2025 Q1	$423K	Sell
2024 Q4	$489K	Buy
2024 Q3	$523K	Hold
2024 Q2	$478K	Buy
2024 Q1	$217K	Hold
2023 Q4	$171K	Hold
2023 Q3	$169K	Hold
2023 Q2	$252K	Buy